1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S122000

Reexamination Certificate

active

07067528

ABSTRACT:
Hydrates of N-[1-butyl-4-[3-[3-(hydroxy)propoxy]-phenyl]-1,2-dihydro-2-oxo-1,8-naphthyridin-3-yl]-N′-(2,6-diisopropyl-4-aminophenyl)urea hydrochloride of the formula:are quite excellent in stability than amorphous one and are more preferable for medicaments.

REFERENCES:
patent: 5843957 (1998-12-01), Muraoka et al.
patent: 6420381 (2002-07-01), Muraoka et al.
patent: 0842933 (1998-05-01), None
patent: 0947515 (1999-10-01), None
patent: 1 086 948 (2001-03-01), None
patent: 1104763 (2001-06-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3690359

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.